Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2014 (2014), Article ID 195617, 4 pages
http://dx.doi.org/10.1155/2014/195617
Case Report

A Case of Sarcoidosis with Interstitial Lung Disease Mimicking Clinically Amyopathic Dermatomyositis and Rapidly Progressive Interstitial Lung Disease

Division of Rheumatology, Department of Internal Medicine, Tokai University School of Medicine, 142 Shimokasuya, Isehara 259-1193, Japan

Received 14 May 2014; Accepted 20 October 2014; Published 9 November 2014

Academic Editor: Jamal Mikdashi

Copyright © 2014 Shinji Sato et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Takano, K. Oida, Y. Kohri et al., “Dermatomyositis complicated by sarcoidosis,” Nihon Kyobu Shikkan Gakkai Zasshi, vol. 34, no. 11, pp. 1255–1259, 1996. View at Google Scholar · View at Scopus
  2. N. Kubis, F. Woimant, M. Polivka, F. Lhote, J. Mikol, and M. Haguenau, “A case of dermatomyositis and muscle sarcoidosis in a Caucasian patient,” Journal of Neurology, vol. 245, no. 1, pp. 50–52, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. A. C. Brateanu, A. Caracioni, and H. R. Smith, “Sarcoidosis and dermatomyositis in a patient with hemoglobin SC. A case report and literature review,” Sarcoidosis Vasculitis and Diffuse Lung Diseases, vol. 17, no. 2, pp. 190–193, 2000. View at Google Scholar · View at Scopus
  4. Y. Yamamoto, H. Ide, Y. Nishigaki et al., “Pulmonary sarcoidosis in a case of dermatomyositis under long-term steroid therapy,” Nihon Kokyuki Gakkai Zasshi, vol. 40, no. 4, pp. 311–315, 2002. View at Google Scholar · View at Scopus
  5. A. Ito, T. Kazama, and M. Ito, “A unique case of sarcoidosis: Coexistence of sarcoidal granuloma and histological changes consistent with dermatomyositis,” British Journal of Dermatology, vol. 149, no. 2, pp. 430–432, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Nishioka, K. Igawa, Y. Yahata, M. Tani, and I. Katayama, “Simultaneous occurrence of dermatomyositis and systemic sarcoidosis with recurrent breast cancer,” The Journal of Dermatology, vol. 39, no. 5, pp. 485–486, 2012. View at Publisher · View at Google Scholar
  7. S. Sato, M. Hirakata, M. Kuwana et al., “Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis,” Arthritis and Rheumatism, vol. 52, no. 5, pp. 1571–1576, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Sato, K. Hoshino, T. Satoh, T. Fujita, Y. Kawakami, and M. Kuwana, “RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease,” Arthritis and Rheumatism, vol. 60, no. 7, pp. 2193–2200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Nakashima, Y. Imura, S. Kobayashi et al., “The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody,” Rheumatology, vol. 49, no. 3, pp. 433–440, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Hamaguchi, M. Kuwana, K. Hoshino et al., “Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study,” Archives of Dermatology, vol. 147, no. 4, pp. 391–398, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Fujikawa, A. Kawakami, K. Kaji et al., “Association of distinct clinical subsets with myositisspecific autoantibodies towards anti155/140kDa polypeptides, anti-140-kDa polypeptides, and antiaminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a singlecentre, crosssectional study,” Scandinavian Journal of Rheumatology, vol. 38, no. 4, pp. 263–267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Gono, S. Sato, Y. Kawaguchi et al., “Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis,” Rheumatology, vol. 51, no. 9, Article ID kes102, pp. 1563–1570, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Ikeda, K. Takahashi, Y. Yamaguchi, M. Inasaka, M. Kuwana, and Z. Ikezawa, “Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients,” Journal of Dermatology, vol. 38, no. 10, pp. 973–979, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Hoshino, Y. Muro, K. Sugiura, Y. Tomita, R. Nakashima, and T. Mimori, “Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis,” Rheumatology, vol. 49, no. 9, pp. 1726–1733, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Tanizawa, T. Handa, R. Nakashima et al., “HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody,” Respiratory Medicine, vol. 105, no. 9, pp. 1380–1387, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. E. H. Kang, R. Nakashima, T. Mimori et al., “Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis,” BMC Musculoskeletal Disorders, vol. 11, article 223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Chen, D. Wang, X. Shu, R. Nakashima, and G. Wang, “Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis,” Rheumatology International, vol. 32, no. 12, pp. 3909–3915, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Cao, M. Pan, Y. Kang et al., “Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody,” Arthritis Care and Research, vol. 64, no. 10, pp. 1602–1610, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. Z. Chen, M. Cao, M. N. Plana et al., “Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: areview of the literature and a meta-analysis,” Arthritis Care and Research, vol. 65, no. 8, pp. 1316–1324, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Fiorentino, L. Chung, J. Zwerner, A. Rosen, and L. Casciola-Rosen, “The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study,” Journal of the American Academy of Dermatology, vol. 65, no. 1, pp. 25–34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. C. Hall, L. Casciola-Rosen, L. A. Samedy et al., “Anti-melanoma differentiation—associated protein 5—associated dermatomyositis: expanding the clinical spectrum,” Arthritis Care & Research, vol. 65, no. 8, pp. 1307–1315, 2013. View at Publisher · View at Google Scholar
  22. M. Labrador-Horrillo, M. A. Martinez, A. Selva-O'Callaghan et al., “Anti-MDA5 antibodies in a large mediterranean population of adults with dermatomyositis,” Journal of Immunology Research, vol. 2014, Article ID 290797, 8 pages, 2014. View at Publisher · View at Google Scholar
  23. C. Cuesta-Mateos, B. Colom-Fernández, I. Portero-Sainz et al., “Autoantibodies against TIF-1-γ and CADM-140 in Spanish patients with clinically amyopathic dermatomyositis (CADM): clinical significance and diagnostic utility,” Journal of the European Academy of Dermatology and Venereology, 2014. View at Publisher · View at Google Scholar
  24. S. Sato, M. Kuwana, T. Fujita, and Y. Suzuki, “Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease,” Modern Rheumatology, vol. 23, no. 3, pp. 496–502, 2013. View at Publisher · View at Google Scholar · View at Scopus